The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cancer gene therapy using a survivin mutant adenovirus
Open accessAbstract
We have constructed a replication-deficient adenovirus encoding a nonphosphorylatable Thr(34)-->Ala mutant of the apoptosis inhibitor survivin (pAd-T34A) to target tumor cell viability in vitro and in vivo. Infection with pAd-T34A caused spontaneous apoptosis in cell lines of breast, cervical, prostate, lung, and colorectal cancer. In contrast, pAd-T34A did not affect cell viability of proliferating normal human cells, including fibroblasts, endothelium, or smooth muscle cells. Infection of tumor cells with pAd-T34A resulted in cytochrome c release from mitochondria, cleavage of approximately 46-kDa upstream caspase-9, processing of caspase-3 to the active subunits of approximately 17 and 19 kDa, and increased caspase-3 catalytic activity. When compared with chemotherapeutic regimens, pAd-T34A was as effective as taxol and considerably more effective than adriamycin in induction of tumor cell apoptosis and enhanced taxol-induced cell death. In three xenograft breast cancer models in immunodeficient mice, pAd-T34A suppressed de novo tumor formation, inhibited by approximately 40% the growth of established tumors, and reduced intraperitoneal tumor dissemination. Tumors injected with pAd-T34A exhibited loss of proliferating cells and massive apoptosis by in situ internucleosomal DNA fragmentation. These data suggest that adenoviral targeting of the survivin pathway may provide a novel approach for selective cancer gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Self-citationMitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Self-citationAn Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Analysis of human transcriptomes
Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., et al. (1999) · Nature Genetics · doi:10.1038/70487 · Cited by 774
From bench to clinic with apoptosis-based therapeutic agents
Nicholson, D. W. (2000) · Nature · doi:10.1038/35037747 · Cited by 687
An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7
Shin, S., Sung, B.-J., Cho, Y.-S., Kim, H.-J., Ha, N.-C., Hwang, J.-I., Chung, C.-W., Jung, Y.-K., & Oh, B.-H. (2001) · Biochemistry · doi:10.1021/bi001603q · Cited by 674
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Self-citationPleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
Self-citationExpression of survivin and its relationship to loss of apoptosis in breast carcinomas
田中, 慶. (2000) · Medical Entomology and Zoology · doi:10.11501/3179364 · Cited by 559
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
Swisher, S. G., Roth, J. A., Nemunaitis, J., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Connors, D. G., El-Naggar, A. K., Fossella, F., Glisson, B. S., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.763 · Cited by 496
Olie, R. A., Simões‐Wüst, A. P., Baumann, B., Leech, S. H., Fabbro, D., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · PubMed · Cited by 489
Monzó, M., Rosell, R., Felip, E., Astudillo, J., Sánchez, J. J., Maestre, J., Martín, C., Font, A., Barnadas, A., & Abad, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2100 · Cited by 487
Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.289 · Cited by 471
Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma
Grossman, D., McNiff, J. M., Li, F., & Altieri, D. C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00776.x · Cited by 365
Self-citationPrognostic significance of survivin expression in diffuse large B-cell lymphomas.
Adida, C., Haïoun, C., Gaulard, P., Lepage, É., Morel, P., Brière, J., Dombret, H., Reyes, F., Diebold, J., Gisselbrecht, C., et al. (2000) · PubMed · doi:10.1182/blood.v96.5.1921 · Cited by 359
Self-citationKato, J., Kuwabara, Y., Mitani, M., Shinoda, N., Sato, A., Toyama, T., Mitsui, A., Nishiwaki, T., Moriyama, S., Kudo, J., et al. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010320)95:2<92::aid-ijc1016>3.0.co;2-9 · Cited by 345
Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells
O'Connor, D. S., Schechner, J. S., Adida, C., Mesri, M., Rothermel, A. L., Li, F., Nath, A. K., Pober, J. S., & Altieri, D. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64742-6 · Cited by 341
Self-citationStructure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.
Noel, J. P., Verdecia, M. A., Huang, H.-K., Sonnenburg, E. D., Kaiser, D. A., & Hunter, T. R. (2000) · Nature Structural Biology · doi:10.1038/76838 · Cited by 337
Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer
Swana, H. S., Grossman, D., Anthony, J. N., Weiss, R. M., & Altieri, D. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410614 · Cited by 301
Self-citationCaspases Induce Cytochrome c Release from Mitochondria by Activating Cytosolic Factors
Bossy-Wetzel, E., & Green, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17484 · Cited by 299
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Self-citationKurihara, T., Brough, D. E., Kovesdi, I., & Kufe, D. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9180 · Cited by 238
Chen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Cowsert, L. M., Bennett, F., Krajewski, S., Krajewska, M., Welsh, K., et al. (2000) · Neoplasia · doi:10.1038/sj.neo.7900091 · Cited by 207
Griffith, T. S., Anderson, R. D., Davidson, B. L., Williams, R. D., & Ratliff, T. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2886 · Cited by 183
Schreiber, M., Muller, W. J., Singh, G., & Graham, F. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202466 · Cited by 162
BIRinging Chromosomes through Cell Division—And Survivin' the Experience
Reed, J. C., & Bischoff, J. R. (2000) · Cell · doi:10.1016/s0092-8674(00)00076-3 · Cited by 151
Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
Hamada, K., Alemany, R., Zhang, W. W., Hittelman, W. N., Lotan, R., Roth, J. A., & Mitchell, M. F. (1996) · PubMed · Cited by 117
Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Ll, N., Dell, J., Maxwell, E., et al. (1997) · PubMed · Cited by 114
Gurnani, M., Lipari, P., Dell, J., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050959 · Cited by 109
Adenoviral-Mediated p53 Gene Transfer to Non-small Cell Lung Cancer Through Endobronchial Injection
Weill, D., Mack, M. J., Roth, J. A., Swisher, S. G., Proksch, S., Merritt, J., & Nemunaitis, J. J. (2000) · CHEST Journal · doi:10.1378/chest.118.4.966 · Cited by 87
Arafat, W. O., Gómez-Navarro, J., Xiang, J., Barnes, M. N., Mahasreshti, P. J., Alvarez, R. D., Siegal, G. P., Badib, A. O., Buchsbaum, D. J., Curiel, D. T., et al. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0071 · Cited by 55
Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector
Steinwaerder, D. S., Carlson, C. A., Otto, D. L., et al. (2001) · Nature Medicine · doi:10.1038/84696 · Cited by 54
Cited by
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Self-citationSurvivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Self-citationSurvivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
Self-citationApoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 826
Metadata
- Authors
- Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-10-01
- Volume
- 108
- Issue
- 7
- Pages
- 981-990
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2059421587
- Cited by
- 337
- References
- 41
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.